Scarica l'app Stockscreener
28.90
1.26%
0.36
Dopo l'orario di chiusura:
28.90
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRMY Giù?
Forum
Previsione
Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie
US applications for jobless aid rose modestly to 212,000 last week as layoffs remain at historically healthy levels - Bitget
Safe Bulkers, Inc. to Participate in the Dry Bulk Shipping Panel at the DNB Carnegie Energy & Shipping Conference in Oslo - Bitget
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments - Yahoo! Finance Canada
Harmony Biosciences (HRMY) Is Down 20.1% After Reaffirming WAKIX Outlook and Winning Pediatric Approval - simplywall.st
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
UBS Group Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $36.00 - MarketBeat
Harmony Biosciences (HRMY): UBS Lowers Price Target to $36 | HRM - GuruFocus
HC Wainwright Reiterates Buy Rating for HRMY with $55 Target | H - GuruFocus
Harmony Biosciences' (HRMY) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y - Finviz
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up - Finviz
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y - Finviz
Corcept's Q4 Earnings and Revenues Fall Short of Estimates - Finviz
Analysts Offer Insights on Healthcare Companies: ProQR (PRQR), Immunic (IMUX) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry - Investing.com
Harmony Biosciences Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Volatility - Markets Mojo
Bank of America Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $28.00 - MarketBeat
Needham & Company LLC Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2025 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $36 at UBS - StreetInsider
CAVA Group To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
B of A Securities Lowers Harmony Biosciences (HRMY) Price Target to $28 | HRMY Stock News - GuruFocus
Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SWOT Insight - GuruFocus
Harmony Biosciences Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q4 2025 Earnings Call Hi - GuruFocus
Harmony Biosciences (HRMY) Reports Strong Q4 2025 Results, Eyes Blockbuster Revenue - GuruFocus
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $28 at BofA Securities - StreetInsider
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target By Investing.com - Investing.com Canada
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target - Investing.com UK
Truist SecuritiesReinstates $25 target on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Harmony Biosciences Holdings (HRMY) Stock Analysis: Positioned for a 70% Upside in Biotech Sector - DirectorsTalk Interviews
Harmony Biosciences Hits Day Low at $26.03 Amid Price Pressure - Markets Mojo
Harmony Biosciences Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Harmony Biosciences Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Harmony Bio misses Q4 2025 EPS estimates - Investing.com UK
Earnings call transcript: Harmony Bio misses Q4 2025 EPS estimates By Investing.com - Investing.com India
Zacks.com highlights 4 value stocks amid AI-driven market volatility - National Today
HRMY: Record revenue, strong WAKIX growth, and pipeline advances set up blockbuster 2026 - TradingView
Harmony Biosciences Holdings, Inc Reveals Retreat In Q4 Profit - Nasdaq
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates - Yahoo Finance
Harmony Biosciences Q4 Adjusted Net Income Drops, Net Product Revenue Rises; Full-Year 2026 Wakix Revenue Guidance Reiterated - marketscreener.com
Harmony Biosciences Reports $868.5 Million Revenue for 2025, Guidance for 2026 Exceeds $1 Billion - Intellectia AI
Harmony Biosciences Holdings, Inc. SEC 10-K Report - TradingView
Harmony Biosciences misses Q4 earnings despite revenue beat By Investing.com - Investing.com India
Harmony Biosciences misses Q4 earnings despite revenue beat - Investing.com
Earnings Flash (HRMY) Harmony Biosciences Holdings, Inc. Reports Q4 Revenue $243.8M, vs. FactSet Est of $240.3M - marketscreener.com
Harmony Biosciences Hldgs Earnings Review: Q4 Summary - Benzinga
Narcolepsy drug WAKIX nears $1B blockbuster year for Harmony Biosciences - Stock Titan
How The Story On Harmony Biosciences (HRMY) Is Shifting With Wakix Legal And Generic Risks - Yahoo Finance
Harmony Biosciences Shares Fall After Deutsche Bank Downgrade - marketscreener.com
Harmony Biosciences (HRMY) Faces Downgrades Amid Legal Concerns - GuruFocus
Harmony Biosciences tumbles following Deutsche Bank, Truist downgrades - Seeking Alpha
FDA Accepts Roche's NDA Seeking Approval for Breast Cancer Drug - Finviz
Amicus' Q4 Earnings Miss, Higher Product Sales Drive Y/Y Revenues - TradingView
Harmony Biosciences Stock Slides on Wakix Patent Fears - TipRanks
Harmony Biosciences (NASDAQ:HRMY) Stock Rating Lowered by Truist Financial - MarketBeat
Deutsche Bank cuts Harmony Biosciences stock rating on patent risk By Investing.com - Investing.com India
3.01%
2.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):